Concepedia

Virginie Sanguin‐Gendreau

VS

Statistics

Publications

21

Citations

1.2K

H-Index

19

Active since

2007

Affiliations

McGill University(Current)

McGill University Health Centre

University of California, Davis

Cancer Research UK Scotland Institute

National Cancer Institute

Virginie Sanguin‐Gendreau is an author at McGill University specializing in oncology, medicine, and oncogenic signaling pathways.

ORCID

Publications per year

2007–2024

21

Publications

21

Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression

Hicham Lahlou, Virginie Sanguin‐Gendreau, Dongmei Zuo et al. · Proceedings of the National Academy of Sciences · 2007 · 195 citations · Full text

, , +17

The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer

Tarek Taifour, Sherif Samer Attalla, Dongmei Zuo et al. · Immunity · 2023 · 183 citations · Full text

, , +17

ShcA signalling is essential for tumour progression in mouse models of human breast cancer

Josie Ursini‐Siegel, W. Rod Hardy, Dongmei Zuo et al. · The EMBO Journal · 2008 · 159 citations · Full text

, , +16

β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression

Babette Schade, Robert Lesurf, Virginie Sanguin‐Gendreau et al. · Cancer Research · 2013 · 77 citations

, , +17

Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development

Josie Ursini‐Siegel, Ashish Rajput, Huiling Lu et al. · Molecular and Cellular Biology · 2007 · 59 citations · Full text

, , +17

1–5 of 21